Our previous study on 336 patients showed that this nonfunctional TP53 variant is found mainly in patients treated with chlorambucil (CLB), an alkylating drug that had been widely used to treat CLL patients before the development of individualized therapy [18]. The gene discussed is TP53; the disease is B-cell chronic lymphocytic leukemia.